Literature DB >> 10783261

Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1.

J P Davies1, B Levy, Y A Ioannou.   

Abstract

Niemann-Pick type C1 (NPC1) disease is caused by defects in the NPC1 protein, which result in perturbation of subcellular cholesterol transport. To identify related proteins that may be involved in subcellular cholesterol trafficking, the expressed sequence tag (EST) database was searched to find homologues of human NPC1. A short, weakly similar EST was identified and used to obtain a full-length human cDNA of about 5 kb and two alternatively spliced transcripts. The gene, named NPC1L1, was mapped to chromosome 7p13, contained 20 exons, including an unusually large 1526-bp exon 2, and spanned approximately 29 kb. In contrast to NPC1, the NPC1L1 putative promoter region contained a sterol-regulatory element. The predicted protein shared 42% identity and 51% similarity with NPC1. Interestingly, NPC1L1 contains the conserved amino-terminal "NPC1 domain" and the putative sterol-sensing domain, providing strong evidence that it is related to human NPC1 and suggesting that these may comprise a new family of NPC1-related proteins. However, the two differ with respect to their putative intracellular targeting signals. Collectively, these data suggest that NPC1L1 and NPC1 form part of a family of related proteins that may have similar functions at different subcellular locations, perhaps at sequential steps of the same cholesterol transport pathway. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783261     DOI: 10.1006/geno.2000.6151

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  60 in total

Review 1.  ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis.

Authors:  Lily Jakulj; Maud N Vissers; Michael W T Tanck; Barbara A Hutten; Frans Stellaard; John J P Kastelein; Geesje M Dallinga-Thie
Journal:  J Lipid Res       Date:  2010-06-25       Impact factor: 5.922

2.  Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8).

Authors:  J Mark Brown; Liqing Yu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2009-03

3.  Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake.

Authors:  Liang Ge; Wei Qi; Li-Juan Wang; Hong-Hua Miao; Yu-Xiu Qu; Bo-Liang Li; Bao-Liang Song
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

4.  Oleic acid decreases the expression of a cholesterol transport-related protein (NPC1L1) by the induction of endoplasmic reticulum stress in CaCo-2 cells.

Authors:  Jiangyuan Chen; Qi Li; Ying Zhang; Pu Yang; Yiqiang Zong; Shen Qu; Zhiguo Liu
Journal:  J Physiol Biochem       Date:  2010-12-22       Impact factor: 4.158

Review 5.  Emerging roles of the intestine in control of cholesterol metabolism.

Authors:  Janine-K Kruit; Albert K Groen; Theo J van Berkel; Folkert Kuipers
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 6.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

7.  Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

Authors:  Ryan E Temel; Weiqing Tang; Yinyan Ma; Lawrence L Rudel; Mark C Willingham; Yiannis A Ioannou; Joanna P Davies; Lisa-Mari Nilsson; Liqing Yu
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

8.  Mutations of a Drosophila NPC1 gene confer sterol and ecdysone metabolic defects.

Authors:  Megan L Fluegel; Tracey J Parker; Leo J Pallanck
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

9.  Diosgenin stimulation of fecal cholesterol excretion in mice is not NPC1L1 dependent.

Authors:  Ryan E Temel; J Mark Brown; Yinyan Ma; Weiqing Tang; Lawrence L Rudel; Yiannis A Ioannou; Joanna P Davies; Liqing Yu
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

10.  Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.

Authors:  Yajun Cheng; Fuli Liu; Jun Wu; Yao Zhang; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.